Kamil M. Yenice to Neoplasm Recurrence, Local
This is a "connection" page, showing publications Kamil M. Yenice has written about Neoplasm Recurrence, Local.
Connection Strength
0.045
-
A phase 1 trial utilizing TMI with fludarabine-melphalan in patients with hematologic malignancies undergoing second allo-SCT. Blood Adv. 2023 02 14; 7(3):285-292.
Score: 0.036
-
Intensity-modulated stereotactic radiotherapy of paraspinal tumors: a preliminary report. Neurosurgery. 2004 Apr; 54(4):823-30; discussion 830-1.
Score: 0.010